Skip to main content
Caplight Logo









Imagine Pharma

Imagine Pharma

Private
Pittsburgh, PennsylvaniaHealthcare & Life Scienceshttps://imaginepharma.com/

Last Round

Series A

Oct 31, 2023

Total Funding Raised

$41.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Imagine Pharma is a biotechnology company that develops a drug discovery and development platform focused on oral delivery, therapeutics, and regenerative medicine for conditions such as diabetes and cardiovascular disease.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

oral drug deliverytherapeutic proteinspeptide deliverybiotechnology R&Dislet isolationdrug delivery platformpill form drugsregenerative medicineclinical servicesbiotech licensingoral biologicsislet distributiondrug pipelinebiotech consulting

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Imagine Pharma Comparables

Compare Imagine Pharma with similar companies based on industry and business-model similarity.

Imagine Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CellTrans Inc.
77%
Chiesi Farmaceutici S.p.A.
66%
LyGenesis
65%

Imagine Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 31, 2023
VC RoundJan 9, 2023
VC RoundJul 28, 2022
SeedMay 12, 2021

Key People

Founding team and executive leadership

Ngoc Thai

Co-Chief Executive Officer, Founder And Chief Marketing Officer

Founding Team

Santiago Pujadas

Co-CEO

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors increased 80% MoM, reaching 1.7K.

  • Feb 28, 2025

    Partnered with Designs for Health Inc. to distribute Progenalen Pro Peptide supplement.

Imagine Pharma Filings

Explore SEC and related filing metadata, where available.

Imagine Pharma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Imagine Pharma's valuation, stock price, and market status.

Is Imagine Pharma a public or private company?

Imagine Pharma is a private company.

What is the current stock price of Imagine Pharma?

Imagine Pharma is a private company with no public stock price. No recent secondary market data is available.

How much is Imagine Pharma worth (valuation)?

Valuation information for Imagine Pharma is not publicly available.

Can I buy Imagine Pharma stock?

Imagine Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Imagine Pharma's last funding round?

Imagine Pharma's most recent funding round was Series A on October 31, 2023.

Who are the main investors in Imagine Pharma?

Investor information for Imagine Pharma is not publicly disclosed.

Will Imagine Pharma IPO soon?

No public IPO plans have been announced for Imagine Pharma.

How can I track Imagine Pharma secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Imagine Pharma's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPittsburgh, Pennsylvania
Employee Range11
Year Founded2016
Last FundingOct 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?